IPS TMS for Patients with PTSD
Recruiting
18 years - 60 years
All
Phase
1
120 participants needed
1 Location
Brief description of study
This study will be the first of its kind to explore the impact of continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) on arousal symptoms among patients with posttraumatic stress disorder (PTSD). We will demonstrate that IPS cTBS results in significant target engagement in the form of reduction in anxiety-potentiated startle (APS) compared to sham cTBS and will identify the ideal dose of cTBS.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: PTSD
-
Age: 18 years - 60 years
-
Gender: All
Male or Female, Age 18-60, Diagnosed with PTSD, right-handed, no metal implants, not pregnant, no history of seizures/seizure disorders, ability to read and write in English
Updated on
02 Jul 2025.
Study ID: 21-0951
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or